Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3249]

LP-284 targets non-Hodgkin's lymphoma and DNA damage repair deficiency

LP-284 targets non-Hodgkin's lymphoma and DNA damage repair deficiency

Prediction tool developed to determine benefit of blood cancer treatment

Prediction tool developed to determine benefit of blood cancer treatment

The use of genomic sequencing panels to personalise cancer treatment is beneficial in only 5% of the patients in whom they are currently used

The use of genomic sequencing panels to personalise cancer treatment is beneficial in only 5% of the patients in...

Further hope for base-edited T-cell therapy to treat resistant leukaemia

Further hope for base-edited T-cell therapy to treat resistant leukaemia

Study brings new understanding of multiple myeloma evolution

Study brings new understanding of multiple myeloma evolution

Immunotherapy for blood cancer: Remote destruction of tumour cells demonstrated

Immunotherapy for blood cancer: Remote destruction of tumour cells demonstrated

EHA 2023: Selinexor subgroup data from the BOSTON trial highlights its clinical potential in R/R Multiple Myeloma

EHA 2023: Selinexor subgroup data from the BOSTON trial highlights its clinical potential in R/R Multiple Myeloma

Study uncovers how B cells react to skin cancer

Study uncovers how B cells react to skin cancer

Study uncovers role of ultraviolet radiation in development of rare leukaemia in the skin

Study uncovers role of ultraviolet radiation in development of rare leukaemia in the skin

ASCO 2023: Radiotherapy may not be necessary after chemoimmunotherapy for primary mediastinal B-cell lymphoma

ASCO 2023: Radiotherapy may not be necessary after chemoimmunotherapy for primary mediastinal B-cell lymphoma

More from ecancer